annual cash & cash equivalents:
$572.88M+$2.19M(+0.38%)Summary
- As of today (September 16, 2025), SNDX annual cash & cash equivalents is $572.88 million, with the most recent change of +$2.19 million (+0.38%) on December 31, 2024.
- During the last 3 years, SNDX annual cash & cash equivalents has risen by +$132.83 million (+30.19%).
- SNDX annual cash & cash equivalents is now at all-time high.
Performance
SNDX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$455.23M-$56.96M(-11.12%)Summary
- As of today (September 16, 2025), SNDX quarterly cash & cash equivalents is $455.23 million, with the most recent change of -$56.96 million (-11.12%) on June 30, 2025.
- Over the past year, SNDX quarterly cash & cash equivalents has increased by +$30.14 million (+7.09%).
- SNDX quarterly cash & cash equivalents is now -20.54% below its all-time high of $572.88 million, reached on December 31, 2024.
Performance
SNDX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SNDX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | +7.1% |
| 3 y3 years | +30.2% | +24.1% |
| 5 y5 years | +858.4% | +143.6% |
SNDX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +30.2% | -20.5% | +34.7% |
| 5 y | 5-year | at high | +858.4% | -20.5% | +167.3% |
| alltime | all time | at high | >+9999.0% | -20.5% | +8894.9% |
SNDX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $455.23M(-11.1%) |
| Mar 2025 | - | $512.20M(-10.6%) |
| Dec 2024 | $572.88M(+0.4%) | $572.88M(+47.0%) |
| Sep 2024 | - | $389.61M(-8.3%) |
| Jun 2024 | - | $425.10M(-2.2%) |
| Mar 2024 | - | $434.58M(-23.9%) |
| Dec 2023 | $570.70M(+19.9%) | $570.70M(+57.0%) |
| Sep 2023 | - | $363.56M(-8.8%) |
| Jun 2023 | - | $398.80M(-7.8%) |
| Mar 2023 | - | $432.39M(-9.1%) |
| Dec 2022 | $475.80M(+8.1%) | $475.80M(+40.8%) |
| Sep 2022 | - | $337.95M(-7.9%) |
| Jun 2022 | - | $366.91M(-7.8%) |
| Mar 2022 | - | $398.05M(-9.5%) |
| Dec 2021 | $440.05M(+50.1%) | $440.05M(+91.5%) |
| Sep 2021 | - | $229.83M(-9.2%) |
| Jun 2021 | - | $253.25M(-6.7%) |
| Mar 2021 | - | $271.33M(-7.5%) |
| Dec 2020 | $293.18M(+390.5%) | $293.18M(+72.2%) |
| Sep 2020 | - | $170.27M(-8.9%) |
| Jun 2020 | - | $186.87M(+88.5%) |
| Mar 2020 | - | $99.12M(+65.8%) |
| Dec 2019 | $59.77M | $59.77M(-17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $72.34M(-10.3%) |
| Jun 2019 | - | $80.62M(-13.2%) |
| Mar 2019 | - | $92.84M(+14.6%) |
| Dec 2018 | $81.01M(-37.7%) | $81.01M(-9.7%) |
| Sep 2018 | - | $89.70M(-8.9%) |
| Jun 2018 | - | $98.49M(-13.1%) |
| Mar 2018 | - | $113.32M(-12.9%) |
| Dec 2017 | $130.08M(+23.3%) | $130.08M(+7.8%) |
| Sep 2017 | - | $120.69M(-7.2%) |
| Jun 2017 | - | $130.06M(+40.0%) |
| Mar 2017 | - | $92.89M(-11.9%) |
| Dec 2016 | $105.48M(+21.9%) | $105.48M(-8.8%) |
| Sep 2016 | - | $115.72M(-7.8%) |
| Jun 2016 | - | $125.51M(-6.1%) |
| Mar 2016 | - | $133.72M(+1038.8%) |
| Dec 2015 | $86.54M(+612.8%) | - |
| Dec 2014 | $12.14M(-15.2%) | - |
| Sep 2014 | - | $11.74M(+132.0%) |
| Jun 2014 | - | $5.06M(-47.0%) |
| Mar 2014 | - | $9.55M(-33.3%) |
| Dec 2013 | $14.31M(+1913.2%) | $14.31M(+179.6%) |
| Sep 2013 | - | $5.12M |
| Dec 2012 | $711.00K(-83.5%) | - |
| Dec 2011 | $4.31M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SNDX is $572.88M
What is the all time high annual cash & cash equivalents for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $572.88M
What is Syndax Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SNDX annual cash & cash equivalents has changed by +$2.19M (+0.38%)
What is Syndax Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SNDX is $455.23M
What is the all time high quarterly cash & cash equivalents for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $572.88M
What is Syndax Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SNDX quarterly cash & cash equivalents has changed by +$30.14M (+7.09%)